Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 214.00
Ask: 215.00
Change: 4.00 (1.90%)
Spread: 1.00 (0.467%)
Open: 210.00
High: 216.00
Low: 210.00
Prev. Close: 211.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Court Sanction of the Scheme of Arrangement

24 Feb 2021 16:24

RNS Number : 2473Q
TP ICAP PLC
24 February 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

24 February 2021

 

TP ICAP plc

Corporate Reorganisation - Court Sanction of the Scheme of Arrangement

On 7 January 2021, TP ICAP plc (TP ICAP) announced the publication of a circular (the Circular) and prospectus in connection with a corporate reorganisation pursuant to which it was proposed that a new ultimate holding company be introduced for the TP ICAP group (the Group). The new ultimate holding company, TP ICAP Group plc, is a company registered in Jersey with company number 130617 (New TP ICAP).

The Group's new corporate structure is being implemented by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the Scheme). Pursuant to the Scheme, TP ICAP's existing share capital will be cancelled and TP ICAP Shareholders will receive one New TP ICAP Ordinary Share for each TP ICAP Ordinary Share held immediately before such cancellation.

Further to the announcement on 1 February 2021 in relation to the results of the Court Meeting and General Meeting, TP ICAP announces that the Court has today made an order sanctioning the Scheme and confirming the associated reduction of capital.

The Scheme will become effective upon a copy of the Court Order being delivered to the Registrar of Companies in England and Wales, which is expected to take place on 26 February 2021.

A further announcement will be made when the Scheme becomes effective.

TP ICAP has requested that the premium listing of its securities on the Official List be cancelled and that its securities cease to be admitted to trading on the London Stock Exchange's main market for listed securities with effect from 8.00 a.m. on 26 February 2021. Admission of the New TP ICAP Ordinary Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities is expected to take place by no later than 8.00 a.m. on 26 February 2021. The Group understands that New TP ICAP will remain eligible for inclusion in the FTSE UK Index series.

Capitalised terms used but not defined herein have the meanings given to them in the Circular.

Enquiries:

TP ICAP plc

 

For media enquiries, please contact:

 

William Baldwin-Charles

 

Media Relations Director

 

 

 

+ 44 7834 524833

 

 

Analysts and Investors please contact:

 

Al Alevizakos

 

Head of Investor Relations

 

 

 

 

+ 44 7999 912672

Important Notices

This announcement has been prepared by and is the sole responsibility of TP ICAP. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Each of TP ICAP and New TP ICAP and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise this announcement whether as a result of new information, future developments or otherwise (save to the extent required by the FCA, the London Stock Exchange or by applicable law, the Listing Rules or the Disclosure Guidance and Transparency Rules). The information in this announcement is subject to change.

NEW TP ICAP ORDINARY SHARES HAVE NEITHER BEEN MARKETED TO, NOR ARE AVAILABLE FOR PURCHASE OR EXCHANGE, IN WHOLE OR IN PART, BY, THE PUBLIC IN THE UNITED KINGDOM OR ELSEWHERE IN CONNECTION WITH THE INTRODUCTION OF THE NEW TP ICAP ORDINARY SHARES TO THE OFFICIAL LIST. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF AN INVITATION OR OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN INVITATION OR OFFER TO BUY OR SUBSCRIBE FOR ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT SHALL BE SOLD, ISSUED, SUBSCRIBED FOR, PURCHASED, EXCHANGED OR TRANSFERRED IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAW.

Notice to United States residents

TP ICAP Shareholders should note that the Scheme is subject to UK procedural and disclosure requirements (which are different from those of the United States) and is proposed to be implemented through a scheme of arrangement in accordance with English company law. As such, the New TP ICAP Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the Securities Act) and will be issued in reliance upon the exemption from the registration requirements of the Securities Act provided by section 3(a)(10) thereof and also will not be subject to the proxy solicitation rules under the US Securities and Exchange Act of 1934, as amended. The financial information included in the Prospectus has been prepared in accordance with IFRS and thus may not be comparable to the financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States.

TP ICAP Shareholders should be aware that the Scheme and the ownership of New TP ICAP Ordinary Shares may have tax consequences in the United States. TP ICAP Shareholders are advised to consult their own tax advisors to determine the particular tax consequences to them of the Scheme.

The New TP ICAP Ordinary Shares to be issued in connection with the Scheme have not been approved or disapproved by the US Securities and Exchange Commission or any securities regulatory authorities of any state of the United States, nor have such authorities passed upon or determined the fairness or merits of such securities or upon the adequacy or accuracy of the information contained in this document. Any representation to the contrary is a criminal offence in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOAFLFFRFLISFIL
Date   Source Headline
12th Oct 20203:29 pmRNSDirector/PDMR Shareholding
9th Oct 20203:07 pmRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSProposed Acquisition of Liquidnet
29th Sep 20206:26 pmRNSDiscussions re proposed acquisition of Liquidnet
10th Sep 20202:45 pmRNSDirectorate Change
7th Aug 20207:00 amRNSFinancial and Interim Management Report
31st Jul 20201:43 pmRNSAcquisition of Louis Capital
31st Jul 20207:00 amRNSDirectorate Change
6th Jul 202010:58 amRNSHolding(s) in Company
6th Jul 202010:49 amRNSHolding(s) in Company
25th Jun 20208:56 amRNSHolding(s) in Company
24th Jun 202010:31 amRNSDirector/PDMR Shareholding
23rd Jun 20205:18 pmRNSHolding(s) in Company
17th Jun 202012:09 pmRNSHolding(s) in Company
13th May 20206:08 pmRNSResult of AGM
13th May 20207:00 amRNSTrading Update Q1 2020
12th May 20204:26 pmRNSHolding(s) in Company
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.